Glial Tumor Invasion: A Role for the Upregulation and Cleavage of BEHAB/Brevican
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Glial tumors, gliomas, are the most common primary intracranial tumors. Their distinct ability to invade the normal surrounding tissue makes them difficult to control and nearly impossible to completely remove surgically, and it accounts for the extraordinarily high lethality associated with gliomas. The ability of these transformed glial cells to invade the normal surrounding tissue is relatively unique in the adult CNS, which under most circumstances, is inhibitory to cell movement. The extracellular matrix (ECM) can modulate, in part, the permissiveness of a tissue to cell movement. Accordingly, the ability of gliomas to modify the ECM of the CNS may mediate the invasiveness of these cells. One ECM molecule that shows dramatic upregulation in gliomas is BEHAB (brain enriched hyaluronan binding)/brevican, a brain-specific chondroitin sulfate proteoglycan. BEHAB/brevican expression is also upregulated during periods of increased glial cell motility in development and following brain injury. Experimental evidence suggests that in glioma, in addition to upregulation of BEHAB/brevican, proteolytic processing of the full-length protein also may contribute to invasion. Here, the authors present a review of the literature on glial tumor invasion by modulation of the ECM and propose a two-step model for BEHAB/brevican’s role in this process.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Purification and Cloning of Aggrecanase-1: A Member of the ADAMTS Family of Proteins
Tortorella, M. D., Burn, T. C., Pratta, M. A., Abbaszade, I., Hollis, J. M., Liu, R., Rosenfeld, S. A., Copeland, R. A., Decicco, C. P., Wynn, R., et al. (1999) · Science · doi:10.1126/science.284.5420.1664 · Cited by 686
Lecticans: organizers of the brain extracellular matrix
Yamaguchi, Y. (2000) · Cellular and Molecular Life Sciences · doi:10.1007/pl00000690 · Cited by 642 · cited 1×
“BEHAB/brevican may, there fore, act as a mo lec u lar bridge be tween the ECM and the cell sur - face (Yamaguchi 2000); BEHAB/brevican could bind HA of the ECM and in ter act si mul ta neously with the sur face of a cell, ei ther di rectly or in di rectly through other cell sur face-ECM com plexes…”
BackgroundAspberg, A., Miura, R., Bourdoulous, S., Shimonaka, M., Heinegård, D., Schachner, M., Ruoslahti, E., & Yamaguchi, Y. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.19.10116 · Cited by 275
Sheppard, A., Hamilton, S., & Pearlman, A. (1991) · The Journal of Neuroscience · doi:10.1523/jneurosci.11-12-03928.1991 · Cited by 249
Gary, S. C., Zerillo, C. A., Chiang, V. L., Gaw, J. U., Gray, G., & Hockfield, S. (2000) · Gene · doi:10.1016/s0378-1119(00)00362-0 · Cited by 36
Self-citation
Cited by
Liang, Y., Diehn, M., Watson, N., Bollen, A. W., Aldape, K. D., Nicholas, M. K., Lamborn, K. R., Berger, M. S., Botstein, D., Brown, P. O., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402870102 · Cited by 503
Extracellular matrix of the central nervous system: from neglect to challenge
Zimmermann, D. R., & Dours-Zimmermann, M. T. (2008) · Histochemistry and Cell Biology · doi:10.1007/s00418-008-0485-9 · Cited by 465
“In addition, glioblastomas display elevated levels of brevican and its proteolytic fragments (Nutt et al. 2001) are associated with an increased expression of ADAMTS-5 and, although somewhat controversial, possibly also with ADAMTS-4 (Held-Feindt et al. 2006; Nakada et al. 2005).”
BackgroundTenascin-C induced signaling in cancer
Orend, G., & Chiquet-Ehrismann, R. (2006) · Cancer Letters · doi:10.1016/j.canlet.2006.02.017 · Cited by 384
Chondroitin sulphate proteoglycans: preventing plasticity or protecting the CNS?
Rhodes, K. E., & Fawcett, J. W. (2004) · Journal of Anatomy · doi:10.1111/j.1469-7580.2004.00261.x · Cited by 296
Extracellular matrix abnormalities in schizophrenia
Berretta, S. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.08.010 · Cited by 179
Metadata
- Authors
- Nutt, C. L., Matthews, R. T., & Hockfield, S.
- Venue
- The Neuroscientist
- Publisher
- SAGE Publications
- Published
- 2001-04
- Volume
- 7
- Issue
- 2
- Pages
- 113-122
- ISSN
- 1073-8584 (ISSN-L)
- 1089-4098
- OpenAlex
- W2109500072
- Cited by
- 49
- References
- 5
- FWCI
- 0.86
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Glial Tumor Invasion: A Role for the Upregulation and Cleavage of BEHAB/Brevican. https://app.cochat.ai/papers/10.1177/107385840100700206
- The paper
- Nutt, C. L., Matthews, R. T., & Hockfield, S. (2001). Glial Tumor Invasion: A Role for the Upregulation and Cleavage of BEHAB/Brevican. The Neuroscientist. https://doi.org/10.1177/107385840100700206
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.